Vaccine Development Challenges: Viral Mutation, Antigenic Drift & Shift
Viral genetic variation challenges vaccine development:
- Antigenic drift – Accumulated mutations (e.g., influenza) alter surface proteins, reducing antibody effectiveness.
- Antigenic shift – Major genetic reassortment (e.g., influenza A) creates novel subtypes unrecognized by immunity.
- Immune escape – Viruses like HIV rapidly mutate surface proteins to evade antibodies.
- Drug-resistant variants – Antiviral pressure selects resistant mutants, complicating vaccines.
Strategies include broad-spectrum vaccines targeting conserved regions, genomic surveillance, and mRNA platforms for rapid adaptation.
Viral Infections - Related Articles
- The Black Death and Anti-Jewish Persecution: Historical Context
- Protect Yourself: Understanding and Preventing SARS Infection
- COVID-19 Vaccine and Quarantine: Do You Need to Isolate After Vaccination?
- Understanding Internal Viral Infections: Causes & Types
- Latent Viral Infections: Mechanisms, Examples & Management
- Viral Infection: The Initial Attachment Step Explained
- T4 Bacteriophage: Lytic Cycle, Bacterial Infection, and Baltimore Classification
